FDMT 4D MOLECULAR THERAPEUTICS IN
2026Q1 · CUSIP 35104E100 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
146
Δ holders QoQ
-7
Breadth percentile
Top 82%
Whale holders
74
Δ whales
-7
Inst. holding value
$439M
New positions
24
Closed positions
31
Price momentum (1Q)
-11.8%
Put / Call
3/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 7% | -41.9% | -65.2% |
| 2023Q3 | Top 17% | +148.3% | +135.7% |
| 2022Q2 | Top 13% | +44.7% | +98.2% |
Options Sentiment
Put holders
3
QoQ: +1
Call holders
3
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.57
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)